What is the typical purity verification process at SaiyanMed?

At SaiyanMed, the typical purity verification process is a multi-layered, independently audited system that begins with raw material selection and ends with a publicly verifiable Certificate of Analysis (CoA) for every single batch. The core of this process relies on third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing conducted by Janoshik Analytical, a well-known independent laboratory in the research chemical space. Every batch, regardless of peptide type or volume, is sent to Janoshik for analysis. The results, including chromatograms and purity percentages, are uploaded to a publicly accessible database where researchers can verify the batch number themselves. This is not a spot-check or a sample-testing scheme; it is a batch-level commitment. For example, a recent batch of their BPC-157 (Batch #SMBP2409) showed a purity of 99.7% by HPLC, with a mass spec confirming the correct molecular weight of 1419.6 Da. The process is designed to eliminate the opacity that plagues many suppliers who either skip testing or use in-house labs with questionable standards.

Raw Material Sourcing and Pre-Screening

The verification process at saiyanmed starts before any peptide is synthesized. Eric, the founder with a Materials Science background from a top Chinese university, built the company around the principle that raw material quality dictates final product purity. SaiyanMed selects premium raw materials from verified suppliers who provide their own CoAs and batch traceability. These raw materials undergo an initial in-house visual inspection and solubility test. But the real gatekeeping happens at the supplier level: SaiyanMed only works with manufacturers who can provide a complete audit trail, including the source of the amino acids, the protecting groups used, and the synthesis logs. This pre-screening eliminates common contaminants like residual solvents, truncated peptides, or unreacted starting materials. Data from their internal logs shows that approximately 8% of raw material batches from potential suppliers are rejected at this stage due to incomplete documentation or suspicious purity claims.

Lyophilization and Production Controls

After synthesis, the peptide enters the lyophilization (freeze-drying) process. This is a critical step where many suppliers cut corners, leading to peptide degradation or moisture content issues. SaiyanMed controls every step of the lyophilization process, using a programmed freeze-dry cycle that maintains a specific temperature gradient and vacuum pressure. The final product is a loose, fluffy powder or a solid plug, depending on the peptide. Each vial is then sealed under an inert argon atmosphere to prevent oxidation. The production facility maintains a controlled environment with temperature and humidity logs. For instance, the cleanroom where filling occurs is kept at 20-22°C with relative humidity below 30%. These parameters are logged and reviewed before any batch is released for third-party testing. The production team also performs a visual inspection of every vial for cosmetic defects, such as cracks, cloudiness, or abnormal cake formation. Any vial that fails this visual check is discarded, typically around 1-2% of a production run.

Independent Third-Party Testing Protocol

The cornerstone of the purity verification process is the mandatory third-party testing at Janoshik Analytical. This is not optional. Every batch is assigned a unique batch number that is printed on the vial label and included in the product listing on the website. SaiyanMed ships a sample from that batch directly to Janoshik, who performs HPLC to determine purity percentage and identify any peptide-related impurities, and MS to confirm the molecular identity. The results are published on Janoshik's public verification page. Researchers can go to that page, enter the batch number, and see the full report, including the HPLC chromatogram, the mass spectrum, and the calculated purity. For example, a recent report for a batch of Semaglutide (Batch #SMSE2407) showed a purity of 99.5% with no detectable dipeptide impurities or oxidation products. The report also includes the retention time, the peak area, and the theoretical vs. observed mass. This level of transparency is rare in the industry, where many suppliers either hide the CoA or provide a generic one that doesn't match the batch shipped.

Verification Data and Batch Consistency

To provide a concrete picture of the verification results, here is a summary of recent batch data from SaiyanMed's public records. This table shows the peptide, batch number, reported purity by HPLC, and the date of the Janoshik report. All data is directly from the independent lab reports and is publicly verifiable.

This data shows a consistent purity level above 98.5% across all tested batches. The slight variation between batches (e.g., MOTS-c at 98.9% vs. BPC-157 at 99.7%) is normal for research-grade peptides and reflects the inherent complexity of synthesizing different sequences. The key point is that every batch is tested, and the results are publicly available. This contrasts with suppliers who only test one batch per year or who provide a CoA from their own in-house lab that may not be reliable.

Shipping and Storage Integrity

Purity verification doesn't end at the lab report. The physical handling and shipping process can degrade a peptide if not done correctly. SaiyanMed ships from a US-based warehouse, which reduces transit time and exposure to temperature extremes for domestic researchers. All vials are packed in insulated containers with ice packs during warmer months. The shipping materials are designed to maintain a stable temperature below 25°C for at least 48 hours. For international orders, the packaging includes a desiccant pack to control humidity. The company also provides storage guidelines on the product page, including recommended temperatures (typically -20°C for long-term storage) and reconstitution instructions. This attention to the post-testing phase ensures that the purity verified by Janoshik is preserved until the product reaches the researcher. Data from their shipping logs indicates that less than 0.5% of orders are reported as damaged or compromised during transit, and those are replaced immediately.

Corporate Compliance and Traceability

The entire verification process is backed by a legally registered entity. SaiyanMed operates as Hong Kong BelleEasy Co., Limited (Commercial Registry No. 78941092), located in Kwai Chung, Hong Kong. This legal structure provides a clear chain of accountability. Every batch is traceable from raw material purchase to final shipment. The batch number on the vial links back to the production date, the raw material lot, the synthesis run, and the Janoshik report. This level of traceability is essential for serious research, where reproducibility and material provenance are critical. The company also maintains a communications desk at [email protected] for any questions about the verification process or batch data. Researchers can request additional information, such as the raw material CoA or the synthesis protocol, for any specific batch.